+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030- Product Image
Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925159
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next-generation breast cancer diagnostic and screening market is entering a pivotal phase defined by technological transformation, evolving clinical priorities, and regulatory adaptation. Senior decision-makers face growing complexity and opportunity as advanced solutions reshape patient care, drive operational change, and influence competitive strategies across regions and organizations.

Market Snapshot: Next-Generation Breast Cancer Diagnostic & Screening Market

The next-generation breast cancer diagnostic and screening market grew from USD 21.27 billion in 2024 to USD 23.03 billion in 2025. This sector is expected to expand at a compound annual growth rate (CAGR) of 8.48%, reaching USD 34.67 billion by 2030. Market growth is propelled by increasing clinical demands, innovation in imaging and molecular diagnostics, and the integration of artificial intelligence into workflows. The interplay between regulatory shifts and technological adoption is also shaping strategies for both established providers and new entrants seeking to capture emerging opportunities across the value chain.

Scope & Segmentation

This comprehensive research categorizes the market across a wide range of dimensions, empowering leaders to identify commercial opportunities and tailor strategies:

  • Offerings: Digital pathology, imaging technologies (breast ultrasound, magnetic resonance imaging, mammography), implantable sensors, liquid biopsy, molecular diagnostics (microarrays, next-generation sequencing, PCR-based assays), and wearable devices.
  • Test Types: Genetic tests (BRCA testing, genomic profiling), pathological tests (cytology, histopathology), and protein marker tests (ER/PR tests, HER2 tests).
  • Stages: Advanced, including Stage III and IV; early stages, including Stage I and II.
  • Applications: Early detection (routine mammograms, self-exams), monitoring (recurrence, treatment response), and structured screening programs.
  • End Users: Academic and research institutes, diagnostic laboratories, hospitals, specialty clinics.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Developments: Analysis covers Abbott Laboratories, Agendia Inc., Agilent Technologies, Becton Dickinson, BGI Genomics, Bio-Rad Laboratories, Centogene, Danaher Corporation, Epic Sciences, Exact Sciences, F. Hoffmann-La Roche, Fujifilm Holdings, GE HealthCare, Hologic, Illumina, Invivoscribe, Philips, LabCorp, Merck, Myriad Genetics, Novartis, Oxford Gene Technology, Pfizer, Siemens Healthineers, Thermo Fisher Scientific, and others.

Key Takeaways for Senior Decision-Makers

  • Next-generation diagnostics are driving a shift toward greater precision and patient-centricity, enabled by the integration of artificial intelligence, digital pathology, and real-time monitoring technologies.
  • Molecular and noninvasive diagnostic tools, such as liquid biopsy and sequencing assays, are enabling earlier detection, ongoing treatment tracking, and more informed therapeutic decisions across care pathways.
  • Market segmentation reveals that different stages of disease, types of diagnostic testing, and end-user settings require targeted approaches that optimize workflow, clinical performance, and resource allocation.
  • Leading innovators are forming strategic partnerships—linking technology suppliers, reagent manufacturers, and healthcare providers—to strengthen supply chains, improve interoperability, and accelerate delivery of novel solutions.
  • Regional dynamics demand tailored strategies, as regulatory requirements, health system maturity, and adoption rates differ widely across the Americas, EMEA, and Asia-Pacific.
  • Corporate strategies favor companies that prioritize data security, regulatory compliance, and user-focused design, supporting faster adoption and resilience to emerging operational or geopolitical headwinds.

Tariff Impact on the Breast Cancer Diagnostic & Screening Market

The 2025 United States tariff measures on imaging equipment, reagents, and precision sensors are prompting stakeholders to re-evaluate sourcing, pricing, and supply chain strategies. These policies have triggered investment in domestic manufacturing, supplier diversification, and co-development initiatives. Regulatory adaptation is catalyzing localized innovation and supporting more robust supply chain frameworks, allowing companies to maintain continuity despite short-term disruptions.

Methodology & Data Sources

This report employs a rigorous approach, combining primary interviews with clinicians and R&D leaders, secondary review of peer-reviewed literature and patents, detailed analysis of regulatory filings, and triangulation of shipment and clinical trial data. Scenario planning and expert panels further validate findings, ensuring actionable, balanced insights for decision-makers.

Why This Report Matters to Strategic Planning

  • Enables leadership to anticipate competitive shifts by illuminating segmentation trends, regulatory adaptations, and collaborative opportunities.
  • Supports investment, product development, and partnership decisions with in-depth coverage of emerging technologies, regional dynamics, and leading market players.

Conclusion

As technological momentum accelerates, the next-generation breast cancer diagnostic and screening market offers dynamic strategic opportunities. This report provides the intelligence needed to drive innovation, adapt to regulatory challenges, and position organizations for sustained impact in breast cancer care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiomics and artificial intelligence for personalized breast cancer risk stratification across diverse populations
5.2. Adoption of circulating tumor DNA liquid biopsy assays for early detection of minimal residual disease in breast cancer patients
5.3. Implementation of contrast-enhanced mammography to improve diagnostic specificity in women with dense breast tissue
5.4. Deployment of portable digital breast tomosynthesis units with edge-based AI analytics for community screening programs
5.5. Emergence of direct-to-consumer hereditary breast cancer gene panels following streamlined regulatory approvals
5.6. Expansion of reimbursement policies for advanced molecular breast imaging modalities in routine clinical practice
5.7. Development of deep learning algorithms to reduce false positives and optimize recall rates in mammography screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Next-Generation Breast Cancer Diagnostic & Screening Market, by Offerings
8.1. Introduction
8.2. Digital Pathology
8.3. Imaging Technologies
8.3.1. Breast Ultrasound
8.3.2. Magnetic Resonance Imaging
8.3.3. Mammography
8.4. Implantable Sensors
8.5. Liquid Biopsy
8.6. Molecular Diagnostics
8.6.1. Microarrays
8.6.2. Next-Generation Sequencing
8.6.3. PCR-Based Assays
8.7. Wearable Devices
9. Next-Generation Breast Cancer Diagnostic & Screening Market, by Test Type
9.1. Introduction
9.2. Genetic Tests
9.2.1. BRCA Testing
9.2.2. Genomic Profiling
9.3. Pathological Tests
9.3.1. Cytology
9.3.2. Histopathology
9.4. Protein Marker Tests
9.4.1. ER/PR Tests
9.4.2. HER2 Tests
10. Next-Generation Breast Cancer Diagnostic & Screening Market, by Stage
10.1. Introduction
10.2. Advanced Stage
10.2.1. Stage III
10.2.2. Stage IV
10.3. Early Stage
10.3.1. Stage I
10.3.2. Stage II
11. Next-Generation Breast Cancer Diagnostic & Screening Market, by Application
11.1. Introduction
11.2. Early Detection
11.2.1. Routine Mammograms
11.2.2. Self-Exams
11.3. Monitoring
11.3.1. Recurrence
11.3.2. Treatment Response
11.4. Screening Programs
12. Next-Generation Breast Cancer Diagnostic & Screening Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Specialty Clinics
13. Americas Next-Generation Breast Cancer Diagnostic & Screening Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Next-Generation Breast Cancer Diagnostic & Screening Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Next-Generation Breast Cancer Diagnostic & Screening Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Agendia Inc.
16.3.3. Agilent Technologies, Inc.
16.3.4. Becton, Dickinson and Company
16.3.5. BGI Genomics Co., Ltd.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Centogene N.V.
16.3.8. Danaher Corporation
16.3.9. Epic Sciences, Inc.
16.3.10. Exact Sciences Corporation
16.3.11. F. Hoffmann-La Roche Ltd.
16.3.12. Fujifilm Holdings Corporation
16.3.13. GE HealthCare Technologies, Inc.
16.3.14. Hologic, Inc.
16.3.15. Illumina, Inc.
16.3.16. Invivoscribe, Inc.
16.3.17. Koninklijke Philips N.V.
16.3.18. Laboratory Corporation of America Holdings
16.3.19. Merck & Co., Inc.
16.3.20. Myriad Genetics, Inc.
16.3.21. Novartis AG
16.3.22. Oxford Gene Technology (OGT) Group
16.3.23. Pfizer Inc.
16.3.24. Siemens Healthineers AG
16.3.25. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET: RESEARCHAI
FIGURE 26. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 27. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET: RESEARCHCONTACTS
FIGURE 28. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMPLANTABLE SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMPLANTABLE SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PCR-BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PCR-BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BRCA TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BRCA TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CYTOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ER/PR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ER/PR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HER2 TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HER2 TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ROUTINE MAMMOGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ROUTINE MAMMOGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SELF-EXAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SELF-EXAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY RECURRENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY RECURRENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TREATMENT RESPONSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TREATMENT RESPONSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 173. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 174. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 175. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 176. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 177. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 182. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 183. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 184. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 185. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 186. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 187. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 188. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 189. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 190. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 191. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 192. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 193. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 196. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 197. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 198. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 199. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 224. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 225. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2018-2024 (USD MILLION)
TABLE 226. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MONITORING, 2025-2030 (USD MILLION)
TABLE 227. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IMAGING TECHNOLOGIES, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY GENETIC TESTS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PATHOLOGICAL TESTS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ADVANCED STAGE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY STAGE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY EARLY DETECTION, 2025-2030 (USD MILLION)
TABLE 253.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Next-Generation Breast Cancer Diagnostic & Screening market report include:
  • Abbott Laboratories
  • Agendia Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Centogene N.V.
  • Danaher Corporation
  • Epic Sciences, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • Oxford Gene Technology (OGT) Group
  • Pfizer Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.67 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Breast Cancer Liquid Biopsy Market by Technology (BEAMing, Digital PCR, Next Generation Sequencing), Biomarker Type (Circulating Free DNA, Circulating Tumor Cells, Circulating Tumor DNA), Application, Sample Type, End User, Cancer Stage - Global Forecast 2025-2030 - Product Image

Breast Cancer Liquid Biopsy Market by Technology (BEAMing, Digital PCR, Next Generation Sequencing), Biomarker Type (Circulating Free DNA, Circulating Tumor Cells, Circulating Tumor DNA), Application, Sample Type, End User, Cancer Stage - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Breast Cancer Screening Device Market by Technology (Digital Mammography, Magnetic Resonance Imaging, Positron Emission Tomography), Application (Diagnostic, Screening), End User - Global Forecast 2025-2030 - Product Image

Breast Cancer Screening Device Market by Technology (Digital Mammography, Magnetic Resonance Imaging, Positron Emission Tomography), Application (Diagnostic, Screening), End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic and Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Next-Generation Breast Cancer Diagnostic and Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Breast Cancer Diagnostics - Global Strategic Business Report - Product Image

Breast Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.